We recently announced the development of our new INSTI SARS-CoV-2 Antibody Test. Based on the 1-minute INSTI platform, the test will detect antibodies to SARS-CoV-2, the virus that causes COVID-19. We have been supported by the government’s NRC IRAP, which has provided advice and financial resources to Canadian companies for more than 70 years, helping them bring innovative ideas to market. When completed, the test will be a helpful tool for supporting the medical community in monitoring the spread of the virus.
Our scientists are still hard at work developing the test, but our Chief Scientific Officer, Michelle Zaharik took some time out of her busy schedule to speak to journalists about this exciting news:
Daily Hive: BC company receives over $600K to develop one-minute coronavirus antibody test
Business in Vancouver: B.C. biotech taps federal funding for 60-second COVID-19 test
Prince George Matters: B.C. biotech taps federal funding for 60-second COVID-19 test
360dx: Biolytical Awarded C$633K to Develop One-Minute COVID-19 Antibody Test
BioWorld: Roundup for May 27, 2020
previous article next article more articles
November 3, 2020
Canada’s First HIV Self Test Receives Licence
July 12, 2021
INSTI® HCV Antibody Test
– Now available in Europe
September 19, 2019